Author

David W. Powell

RAND - Cited by 3,431 - Quantile Treatment Effects - Optimal Health Insurance - Income Taxes

Biography

Dr. David W. Powell belongs from the Department of Medicine, Division of Nephrology and Hypertension, University of Louisville School of Medicine, Kentucky at USA. He specialises in the subjects of Medicine, Pharmacology,Inflammation,  Health , Medical science, life biology. He published more than 10 articles in different scientific journals and magazines. 
Title
Cited by
Year
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?
D Powell, RL Pacula, M JacobsonJournal of Health Economics 58 (1), 2018201
420
2018
Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids
A Alpert, D Powell, RL PaculaAmerican Economic Journal: Economic Policy 10 (4), 1-35, 2018201
373
2018
Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose
R Abouk, RL Pacula, D PowellJAMA internal medicine 179 (6), 805-811, 2019201
189
2019
Quantile treatment effects in the presence of covariates
D PowellReview of Economics and Statistics 102 (5), 994-1005, 2020202
169
2020
Origins of the opioid crisis and its enduring impacts
A Alpert, WN Evans, EMJ Lieber, D PowellThe Quarterly Journal of Economics 137 (2), 1139-1179, 2022202
143
2022
How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D
D Powell, RL Pacula, E TaylorJournal of health economics 71, 102286, 2020202
116
2020
The value of working conditions in the United States and implications for the structure of wages
N Maestas, KJ Mullen, D Powell, T Von Wachter, JB WengerAmerican Economic Review 113 (7), 2007-2047, 2023202
104
2023
A transitioning epidemic: how the opioid crisis is driving the rise in hepatitis C
D Powell, A Alpert, RL PaculaHealth Affairs 38 (2), 287-294, 2019201
73
2019
Quantile regression with nonadditive fixed effects
D PowellEmpirical Economics 63 (5), 2675-2691, 2022202
62
2022
Is the rise in illicit opioids affecting labor supply and disability claiming rates?
S Park, D PowellJournal of Health Economics 76, 102430, 2021202
51
2021
The evolving consequences of oxycontin reformulation on drug overdoses
D Powell, RL PaculaAmerican Journal of Health Economics 7 (1), 41-67, 2021202
48
2021
A supply‐side perspective on the opioid crisis
RL Pacula, D PowellJournal of Policy Analysis and Management 37 (2), 438-4, 2018201
46
2018
The state of the science in opioid policy research
MS Schuler, SE Heins, R Smart, BA Griffin, D Powell, EA Stuart, B Pardo, ...Drug and alcohol dependence 214, 108137, 2020202
32
2020
Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policies
BA Griffin, MS Schuler, EA Stuart, S Patrick, E McNeer, R Smart, D Powell, ...BMC medical research methodology 21 (1), 1-19, 2021202
16
2021
Synthetic Control Estimation Beyond Comparative Case Studies: Does the Minimum Wage Reduce Employment?
D PowellJournal of Business & Economic Statistics 40 (3), 1302-1314, 2022202
16
2022
Individual and community factors associated with naloxone co-prescribing among long-term opioid patients: a retrospective analysis
BD Stein, R Smart, CM Jones, F Sheng, D Powell, M SorberoJournal of General Internal Medicine, 1-6, 2021202
15
2021
Does marijuana legalization affect work capacity? evidence from workers’ compensation benefits
R Abouk, KM Ghimire, JC Maclean, D PowellNational Bureau of Economic Research, 2021202
14
2021
Variation in performance of commonly used statistical methods for estimating effectiveness of state-level opioid policies on opioid-related mortality
BA Griffin, MS Schuler, EA Stuart, S Patrick, E McNeer, R Smart, D Powell, ...National Bureau of Economic Research, 2020202
13
2020
Changes in buprenorphine and methadone supplies in the US during the COVID-19 pandemic
AY Chen, D Powell, BD SteinJAMA Network Open 5 (7), e2223708-e2223708, 2022202
11
2022